Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04LTQ
|
|||
| Former ID |
DCL000734
|
|||
| Drug Name |
Buproprion+zonisamide
|
|||
| Synonyms |
Empatic (TN)
Click to Show/Hide
|
|||
| Indication | Obesity [ICD-11: 5B81; ICD-10: E66; ICD-9: 278] | Phase 2 | [1] | |
| Company |
Orexigen Therapeutics
|
|||
| SuperDrug ATC ID |
N03AX15
|
|||
| SuperDrug CAS ID |
cas=068291974
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Solute carrier family 22 member 8 (SLC22A8) | Target Info | Blocker | [2] |
| Pathwhiz Pathway | Kidney Function | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800024638) | |||
| REF 2 | Anti-obesity drugs. Expert Opin Pharmacother. 2008 Jun;9(8):1339-50. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.